An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
about
CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany.Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance.Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer.Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection.Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck.Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base.Chemoradiotherapy of esophageal cancer.Effective health care: management of head and neck cancersImpact of anemia in patients with head and neck cancer treated with radiation therapy.Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapyAlteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?Radiotherapeutic management of locally advanced head and neck cancer.Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.Systemic therapy strategies for head-neck carcinomas: Current statusInduction chemotherapy in the management of squamous cell carcinoma of the head and neck.Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.Combined modality treatment of laryngeal squamous cell carcinoma.Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study.Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.Evaluation of neo-adjuvant, concurrent and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma: a meta-analysis.Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer.Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data.Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.Long-term complete remission of oral cancer after anti-neoplastic chemotherapy as single treatment modality: role of local chemotherapy.Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck.Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx.Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome.High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma.Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
P2860
Q31040425-0D6602C6-95D8-4AB4-8A1E-051471FD2F01Q33328454-B75EE3DE-EDCF-47D5-9BF0-18284E05AAC9Q33336782-D9795D0A-1993-4BBA-9C22-CE3F3FBD0424Q33343214-C526E87D-E85B-481D-A618-E3A9491D9C5CQ33344718-171A22FE-1FCA-4EB1-8F27-C9C7ADDC1B3FQ33687233-BB25314F-5DCF-4E45-AC72-D7DA47266225Q34195878-87277EB5-AFBB-485B-9C60-69E1119C45EFQ34210492-F8E0F0DE-B683-449A-B25B-B85741E75E70Q34278528-188B448A-6147-45C4-B41B-A15D08A73E87Q34394028-DE37CE93-0792-41C7-AC72-094F97B7EF52Q34529177-3521D883-C7D6-4FA0-868C-2648E11BA6C2Q34623415-4866E93C-6E30-4EDC-90A1-AC99E45B5C4AQ34686972-428CC0D1-48E5-4888-9B5A-83A8ADFDAE80Q34725088-9776412C-A7CC-419E-954D-8BBF4144DD46Q35527499-F710F9B6-C718-49AC-BB87-D4EA15596E15Q35989798-06E47DBC-0FF0-4D8C-AA2C-B0F58131CEAEQ35991873-F969D3C7-A7C5-4BF7-BF8D-2993E62F0806Q36304013-75AE4573-E4B9-45DC-8E27-233F0969EFA2Q36390229-46450652-1829-47E1-8FE4-E4C60E9620BFQ36407464-6FA30577-1910-4FB1-9FC9-823E1290967DQ36511014-65276EFE-0DB8-42F0-BB59-00BFC1B780F8Q36529843-571ADD45-3AD7-40B9-9EEF-47EAF9463B13Q36613979-59558EDB-D77C-40B4-BCE5-331E328ABA34Q36695358-425DDCED-15CA-46DE-8F3F-598B514C0271Q36752037-0FCEFC13-D4B0-45E8-8066-0D2BF49BAC02Q36859705-87691BEF-9AE3-451A-94CD-A43D10905F51Q37135687-0E53F536-4261-4607-A4F6-E5DBE865F076Q37364496-67667CB6-23C5-4EBD-B9E2-8F73CCF43728Q39708456-B7FBA229-05F7-42F5-8566-8096E77E8A5FQ41515794-21CE9BBA-1F8C-4CCF-97A0-E9EF63D75360Q41858833-FBFB5017-11EF-4ECE-89A4-0FD87BE639DEQ42590912-A1755F71-3095-45A8-AB6F-C8A389E7D239Q43881544-73023084-2C04-417F-9438-8F9426210566Q43916933-03691CDA-789F-44B7-B730-97BBEC16CC8EQ43956392-2CB560B4-B105-4B86-9C12-111E9124A90DQ44189922-E567C2F3-A7A1-4E06-857D-6D14201ADD01Q44926859-0876487B-6792-402B-84B0-BA557AC4C46CQ44978810-17593352-28F8-4F7E-8FD8-A1726876B325Q46022236-832F7D3B-854B-4865-84F9-207761641B84Q46478559-41EF386F-960A-4E48-ACD5-B1B5E3F996C6
P2860
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
An overview of randomised cont ...... herapy in head and neck cancer
@en
type
label
An overview of randomised cont ...... herapy in head and neck cancer
@en
prefLabel
An overview of randomised cont ...... herapy in head and neck cancer
@en
P2860
P356
P1476
An overview of randomised cont ...... herapy in head and neck cancer
@en
P2093
P2860
P2888
P356
10.1038/BJC.1995.17
P407
P577
1995-01-01T00:00:00Z